Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (6) , 943-952
- https://doi.org/10.1016/j.clinthera.2006.06.012
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled studyThe Pain Clinic, 2003
- The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinicDrug and Alcohol Dependence, 2003
- Chronic opioid therapy for non-cancer painBritish Journal of Anaesthesia, 2001
- Long-term oral opioid therapy in patients with chronic nonmalignant painJournal of Pain and Symptom Management, 1992
- Treatment Principles for the Use of Opioids in Pain of Nonmalignant OriginDrugs, 1991
- Buprenorphine has potent kappa opioid receptor antagonist activityNeuropharmacology, 1987
- Prospective double-blind comparison of buprenorphine and pethidine in ureteric colic.BMJ, 1982
- BuprenorphineDrugs, 1979
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977